The federal government is embarking on a significant pilot program, the Wasteful and Inappropriate Service Reduction (WISeR) Model, which leverages artificial intelligence to influence insurance-coverage decisions within original Medicare. This initiative, spearheaded by the Trump administration and implemented by the Centers for Medicare and Medicaid Services (CMS), aims to curtail unnecessary medical spending and reduce fraud. However, the introduction of AI into the often-contentious realm of prior authorization has ignited a fervent debate, with healthcare providers, patient advocates, and lawmakers expressing profound concerns that this technological advancement could exacerbate existing challenges, potentially leading to increased denials of medically necessary care and creating new obstacles for patients seeking timely treatment.
The Enduring Burden of Prior Authorization
For countless Americans, navigating the labyrinthine process of securing pre-approval for medical care recommended by their physicians is a familiar and often agonizing ordeal. Personal accounts widely document the "tribulations" of patients forced to jump through bureaucratic hoops to persuade health insurers to cover essential prescription medications, critical medical procedures, and other vital services. This process, known as prior authorization, was initially conceived as a crucial safeguard against healthcare overuse and unwarranted spending, intended to encourage the selection of less costly, yet equally effective, alternatives.
However, its implementation has frequently fallen short of this ideal. A substantial majority of physicians, as highlighted by the American Medical Association (AMA), consistently report that prior authorization contributes to significant care delays. These delays can have severe consequences, often leading patients to abandon recommended treatments while awaiting insurers to verify eligibility and confirm medical necessity. The appeals process, while available, only adds further time and complexity to an already stressful situation. Data from a 2025 Commonwealth Fund survey revealed that approximately one in five working-age adults with private insurance reported a denial of physician-recommended medical care for themselves or a family member. Among those who experienced a prior authorization denial, 41 percent reported delayed care, and over a quarter observed a worsening of their health condition as a direct result. Public opinion polls, such as those conducted by KFF, consistently identify prior authorization as a "major burden" on patients.
In the rapidly expanding Medicare Advantage sector—privately run alternatives to original Medicare that now enroll roughly 55 percent of eligible seniors and disabled individuals—insurers issue millions of full or partial claim denials annually based on prior authorization. Federal government reports, including those from the HHS Office of Inspector General (OIG), have documented instances where plans rejected requests for skilled nursing and rehabilitation admissions, even when medically appropriate, raising serious questions about access to care.
AI: A Double-Edged Sword in Healthcare Claims
Theoretically, artificial intelligence, with its unparalleled capacity to rapidly process and analyze vast quantities of information, presents a compelling solution to some of these challenges. Proponents argue that AI could significantly expedite the approval of "unambiguously allowable claims," thereby reducing the agonizing delays that patients currently face. The promise is one of efficiency, automation, and a streamlined administrative burden for both insurers and providers.
However, the reality of "AI-driven prior authorization" is proving to be far more contentious. Resistance is mounting due to serious concerns that AI could inadvertently lead to an increase in wrongful denials of health insurance coverage. A 2025 AMA survey of physicians underscored this apprehension, with a striking 61 percent of doctors expressing worry that AI tools would exacerbate denials of treatments they consider medically necessary. The AMA has been vocal in its advocacy, demanding that insurers provide detailed clinical reasoning for any coverage denials and commit to greater transparency regarding the algorithms that power these AI systems. Health policy analyst Camm Epstein encapsulated this sentiment in an email to Undark, stating unequivocally that "AI should be used to make appropriate care easier to approve, not necessary care easier to deny."
The WISeR Model: A New Frontier for AI in Medicare
Against this backdrop, the Centers for Medicare and Medicaid Services (CMS) initiated the WISeR Model (Wasteful and Inappropriate Service Reduction Model) earlier this year. This demonstration project, currently active in six states and slated to run through December 2031, represents a significant expansion of prior authorization, particularly in original Medicare where its use has historically been limited. The model’s core objective is to reduce waste and fraud within original Medicare by identifying and decreasing "unnecessary procedures."
The WISeR model integrates advanced technologies, notably machine learning, with human clinical review. It is designed to evaluate services that CMS believes are particularly vulnerable to overuse, fraud, and abuse. Examples of targeted services include certain skin and tissue substitutes, electrical nerve stimulator implants, and knee arthroscopy for knee osteoarthritis. The underlying premise is that AI can more effectively flag potentially inappropriate claims for human review, thus optimizing resource allocation and safeguarding taxpayer dollars.
However, this shift towards integrating AI into original Medicare’s prior authorization process has been met with skepticism and outright opposition. Critics argue that expanding prior authorization, even with AI, into a domain where it was previously minimal risks replicating the very problems that plague Medicare Advantage.
Mounting Concerns and Political Pushback
The apprehension surrounding the WISeR model is multi-faceted. Investigations by prominent media outlets and health policy researchers, cited by Zena Wolf of the Center for Health & Democracy, suggest that in its initial months, the model has already caused care delays and denials in some instances across the six pilot states. This contradicts CMS’s stated goal that WISeR will "ensure timely and appropriate Medicare payment for select items and services." Moreover, despite the promise of automation, the model has reportedly imposed a significant administrative burden on healthcare providers, who find themselves grappling with additional work stemming from AI-driven denials.
A particularly troubling aspect of the WISeR model, and a key point of contention, is the compensation structure for the vendors hired to implement the AI-driven prior authorization. These vendors earn a share of what CMS terms "averted expenditures." This direct financial incentive for rejecting care requests raises serious ethical questions about potential conflicts of interest, fueling long-standing concerns that profit motives could lead to policies that discourage patients from receiving medically necessary care. This model, critics argue, could transform AI from a tool for efficiency into a gatekeeper driven by financial gain, rather than patient well-being.
The political ramifications are already evident. Several lawmakers have introduced resolutions and amendments aimed at blocking funding for the WISeR model, citing grave threats to patient access to care. These legislative efforts underscore the deep divisions and anxieties within the political landscape regarding the ethical and practical implications of deploying AI in such a critical area of public health.
Government and Industry Efforts Towards Reform
Recognizing the widespread dissatisfaction with prior authorization, both the government and private insurers have undertaken efforts to introduce reforms. In 2024, the Biden administration issued a rule designed to reduce delays for patients enrolled in government-run health plans and streamline the prior authorization process for physicians. This rule mandated that insurers make urgent prior authorization decisions within 72 hours and non-urgent decisions within seven calendar days. These timeline requirements officially took effect on January 1 of this current year for most public sector health plans.
Concurrently, the Trump administration, alongside major insurers, pledged last year to further streamline and accelerate prior authorization processes. Private insurance companies made a public commitment to standardize electronic requests by 2027 and to actively "reduce the volume of medical services subject to prior authorization" by 2026. This includes commonly performed procedures such as colonoscopies and cataract surgeries, signaling an acknowledgement of the administrative burden these requirements impose. CMS Administrator Mehmet Oz has even issued a stern warning to insurance company executives: ease the burden of prior authorization voluntarily, or face federal regulation. "If you don’t do it yourselves, then we’re going to do it for you," Oz stated, emphasizing the government’s readiness to intervene.
In response to these pressures, health plans recently released industry-based data suggesting a degree of compliance with administration demands. A survey indicated that between June 2025 and April 2026, requests for prior authorization declined by 11 percent. However, it remains "unknown" whether this reduction in requests has translated into a decreased denial rate, leaving a crucial piece of the puzzle unanswered. Furthermore, in a separate industry group survey conducted last year, all responding health plans affirmed that "AI or algorithms without clinician or practitioner review are not used to deny prior authorization requests that involve medical necessity or clinical considerations." Insurers also promised increased transparency regarding the clinical reasoning underpinning prior authorization decisions, an attempt to assuage fears about opaque AI systems.
Broader Implications and the Path Forward
The current landscape reveals a perplexing duality in the government’s approach to prior authorization. On one hand, CMS is expanding its use, particularly with AI, in original Medicare through the WISeR model. On the other hand, the administration is simultaneously pressuring private insurers, including Medicare Advantage plans, to reduce and streamline their prior authorization protocols. This "two minds" approach highlights the inherent tension between cost containment and ensuring patient access to care, a fundamental conflict that AI is now poised to either exacerbate or alleviate.
The challenge of placating detractors and building public trust in AI’s role in healthcare decision-making is substantial. While insurers’ pledges regarding human oversight and transparency are a step in the right direction, skepticism persists. Jared Dashevsky, a physician and founder of Healthcare Huddle, articulates a common frustration: "AI could eliminate barriers, reduce administrative waste, give us more time with patients. But that’s not what’s being built." Instead, he contends, the current trajectory appears to be an "arms race to deny faster and appeal faster," merely automating a "broken system that shouldn’t exist in its current form."
The implications of AI’s expanded role in prior authorization extend far beyond administrative efficiency. There are critical ethical considerations regarding algorithmic bias, ensuring equitable access to care, and maintaining the physician-patient relationship at the core of healthcare decisions. Without robust oversight mechanisms, stringent transparency requirements, and a clear prioritization of patient well-being over financial incentives, the integration of AI into prior authorization risks creating a more efficient, yet potentially more unjust, healthcare system. The ongoing debate underscores a pivotal moment in healthcare policy, where technological advancement meets the deeply human need for timely, affordable, and medically appropriate care.
